Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death.
Jack Gisby,
Candice L Clarke,
Nicholas Medjeral-Thomas,
Talat H Malik,
Artemis Papadaki,
Paige M Mortimer,
Norzawani B Buang,
Shanice Lewis,
Marie Pereira,
Frederic Toulza,
Ester Fagnano,
Marie-Anne Mawhin,
Emma E Dutton,
Lunnathaya Tapeng,
Arianne C Richard,
Paul DW Kirk,
Jacques Behmoaras,
Eleanor Sandhu,
Stephen P McAdoo,
Maria F Prendecki,
Matthew C Pickering,
Marina Botto,
Michelle Willicombe,
David C Thomas,
James E Peters
Apr 08, 2021
End-stage kidney disease (ESKD) patients are at high risk of severe COVID-19. We measured 436 circulating proteins in serial blood samples from hospitalised and non-hospitalised ESKD patients with COVID-19 (n = 256 samples from...